Linzagolix (KLH-2109; OBE-2109) 是一种有效的，非多肽，口服有效的 GnRH 拮抗剂。可用于子宫肌瘤、子宫内膜异位症、子宫腺肌症研究。
货号:ajcx36548
CAS:935283-04-8
分子式:C22H15F3N2O7S
分子量：508.42
溶解度:DMSO : 125 mg/mL (245.86 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存： 现货

Background:

Linzagolix (KLH-2109; OBE-2109) is a potent, non-peptide, and orally active GnRH antagonist. Linzagolix can be used for uterine fibroids, endometriosis, adenomyosis research[1].

[1]. Susan Dababou, et al. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opin Investig Drugs. 2021 Sep;30(9):903-911.